Product Details
| Cat.No. | EDC01202 | Product Name | KMS-12-PE-Cas9 |
|---|---|---|---|
| Species | Human | Cell Line | KMS-12-PE |
| Cellosaurus ID | CVCL_1333 | Cell Line Synonyms | KMS 12 PE, KMS-12_PE, KMS-12PE, KMS12-PE, KMS12PE, Kawasaki Medical School-12-Pleural Effusion |
| Summary |
Predicted to enable extracellular matrix binding activity and identical protein binding activity. Predicted to be involved in signal transduction. Predicted to act upstream of or within extracellular matrix organization. Predicted to be located in extracellular matrix and extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
|
Associated Diseases | Plasma Cell Myeloma |
| Morphology | Suspension | Editing Efficiency | 68% |
| Complete Culture Medium | 90% FBS+10% DMSO | Freezing Medium | 1640+10% FBS |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
STR Profile
| Loci | STR Info (Sample Cell) Sample Cell Line: KMS-12-PE | STR Info (Cell bank) Cell Line: KMS-12-PE | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 9 | 9 | ||
| D2S1338 | 18 | 20 | 18 | 20 |
| D3S1358 | 16 | 16 | ||
| D5S818 | 14 | 14 | ||
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 10 | 16 | 16 | |
| D13S317 | 8 | 8 | ||
| D16S539 | 11 | 11 | ||
| D18S51 | 15 | 15 | ||
| D19S433 | 14 | 14 | ||
| D21S11 | 30 | 32.2 | 30.2 | 32.2 |
| Penta D | 14 | 14 | ||
| Penta E | 12 | 18 | 12 | 18 |
| TPOX | 8 | 11 | 8 | 11 |
| VWA | 14 | 16 | 14 | 16 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
